The pharmaceutical industry is constantly seeking advanced intermediates to facilitate the synthesis of life-saving drugs. Among these, Sodium 2-Hydroxybutyrate, identified by its CAS number 5094-24-6, plays a critical role as a key intermediate in the production of Idelalisib, a targeted therapy for certain cancers. The efficacy and safety of the final drug product are directly linked to the quality of the intermediates used in its synthesis, making the procurement of high-purity Sodium 2-Hydroxybutyrate a paramount concern for manufacturers and researchers.

Sodium 2-Hydroxybutyrate is typically supplied as a white to off-white crystalline powder, with a molecular formula of C4H7NaO3. Its purity is a critical parameter, with specifications often requiring an assay of 98.0% or higher. This level of purity is essential for ensuring that the complex synthetic routes involved in Idelalisib production proceed without unwanted side reactions or the formation of impurities that could compromise the final API. For researchers and buyers, understanding these purity requirements and verifying them through reliable supplier documentation is crucial.

When seeking to purchase Sodium 2-Hydroxybutyrate, it is vital to partner with a manufacturer or supplier that demonstrates a strong commitment to quality control and assurance. This includes providing detailed Certificates of Analysis (CoA) for each batch, which outlines the specific purity and physical properties of the compound. Establishing a relationship with a trusted Sodium 2-Hydroxybutyrate supplier, especially one that can offer competitive pricing and consistent availability, is a strategic imperative for pharmaceutical companies.

The role of intermediates like Sodium 2-Hydroxybutyrate extends beyond mere chemical composition; it represents a critical step in bringing advanced treatments to patients. Therefore, the choice of supplier is not just a matter of cost but also one of reliability and regulatory compliance. Companies looking for a stable supply of this intermediate often turn to manufacturers in China, which have developed robust capabilities in producing high-quality fine chemicals. Exploring options for bulk purchases and obtaining quotations can further optimize the sourcing process.

In conclusion, the consistent supply of high-purity Sodium 2-Hydroxybutyrate is indispensable for the successful manufacturing of Idelalisib. By prioritizing quality assurance and partnering with reputable suppliers, the pharmaceutical industry can continue to develop and deliver innovative treatments. We are committed to being your trusted source for this vital pharmaceutical intermediate.